Tyra Biosciences Income Statement (2020-2026) | TYRA

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
9.16M13.78M41.70M41.90M42.14M42.35M42.54M42.82M42.93M43.02M52.47M52.74M52.87M50.75M53.09M53.23M53.32M53.71M59.47M
Operating items
Research & Development (Quarter)
5.48M7.25M9.64M12.05M10.91M10.40M10.41M12.16M19.27M20.68M17.20M18.00M22.70M22.18M24.96M24.31M25.47M28.19M33.47M39.20M
Selling, General & Administrative (Quarter)
1.15M2.68M5.19M0.19M2.73M4.62M3.93M3.85M4.69M4.96M5.12M5.54M5.91M7.56M6.89M7.14M7.47M8.33M8.53M9.81M
Operating Expenses (Quarter)
6.64M9.93M14.83M15.43M13.64M15.02M14.33M16.01M23.96M25.63M22.32M23.53M28.60M29.74M31.85M31.45M32.94M36.52M42.00M
Other Operating Expenses (Quarter)
3.19M
Operating Income (Quarter)
-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
EBIT (Quarter)
-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.01M0.02M0.35M1.13M2.16M2.45M2.74M2.81M2.80M4.13M4.83M4.59M4.17M3.70M3.35M3.08M2.68M2.69M
Non Operating Income (Quarter)
-0.01M0.00M0.01M0.33M1.14M2.12M2.45M2.74M2.81M2.80M4.13M4.83M4.59M4.17M3.70M3.35M3.08M2.68M2.69M
Other Non Operating Income (Quarter)
0.01M-0.01M
Net income details
EBT (Quarter)
-44.68M-9.75M-34.75M-15.08M-31.32M-12.71M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Profit After Tax (Quarter)
-6.64M-9.93M-14.83M-15.10M-12.51M-12.89M-11.88M-13.27M-21.15M-22.45M-18.19M-18.70M-22.08M-26.55M-28.15M-28.10M-29.86M-33.88M-39.59M
Income from Continuing Operations (Quarter)
-44.68M-9.75M-34.75M-15.08M-31.32M-12.71M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Consolidated Net Income (Quarter)
-44.68M-9.75M-34.75M-15.08M-31.32M-12.71M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Income towards Parent Company (Quarter)
-44.68M-9.75M-34.75M-15.08M-31.32M-12.71M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Net Income towards Common Stockholders (Quarter)
-44.68M-9.75M-34.75M-15.08M-31.32M-12.71M-67.78M-70.61M-61.13M-22.83M-75.03M-69.07M-135.01M-25.87M-41.61M-41.89M-75.89M-34.03M-363.74M
Additional items
EPS (Basic) (Quarter)
-4.88-0.71-0.84-0.36-0.75-0.30-1.60-1.66-1.43-0.53-1.44-1.18-2.29-0.45-0.70-0.70-1.27-0.57-5.89
EPS (Diluted) (Quarter)
-4.88-0.71-0.84-0.36-0.75-0.30-1.60-1.66-1.43-0.53-1.44-1.18-2.29-0.45-0.70-0.70-1.27-0.57-5.89
Shares Outstanding (Quarter)
9.16M13.78M41.55M41.78M42.00M41.88M42.39M42.59M42.87M42.70M52.23M58.67M58.87M57.22M59.34M59.55M59.67M59.60M61.75M
Shares Outstanding (Diluted) (Quarter)
9.16M13.78M41.55M41.78M42.00M41.88M42.39M42.59M42.87M42.70M52.23M58.67M58.87M57.22M59.34M59.55M59.67M59.60M61.75M
EBITDA (Quarter)
-6.64M-9.93M-14.83M-15.43M-13.64M-15.02M-14.33M-16.01M-23.96M-25.63M-22.32M-23.53M-28.60M-29.74M-31.85M-31.45M-32.94M-36.52M-42.00M
Interest Expenses (Quarter)
38.04M-0.18M19.94M18.81M-0.15M55.90M57.34M39.98M56.84M50.37M111.00M0.30M13.46M13.80M46.02M0.20M324.43M